HERMES PHARMA, a company involved in user-friendly oral dosage forms, will invest €25 million to further bolster its manufacturing capabilities. The investment will include new equipment, increased production and storage capacity, and greater operational efficiency to meet growing market demand for user-friendly oral dosage forms.

The investment will add: large-volume coating equipment for taste-masking, filling and packaging lines for ODGs and instant drinks, expanded GMP manufacturing and storage capacity, and optimized flow of inventory/goods on the shop floor.

“As pharmaceutical companies race to find ways to better serve patients and differentiate themselves in a competitive market, we’re seeing unprecedented demand for more patient-centric products,” said Andreas Ulrich, COO of HERMES PHARMA . “Our latest investment will help us meet that demand, delivering ever greater service for our customers, while also helping us serve new customers across different market segments. We look forward to getting new and improved user-friendly dosage forms to patients quickly and more efficiently than ever before.”